Who Owns bioAffinity Technologies Stock?
NASDAQ: BIAFHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 5.56%
- Held by insiders
- 0.82%
- Institutional holders
- 23
- Institutions 5.6%
- Insiders 0.8%
- Public and other 93.6%
Who owns bioAffinity Technologies stock?
Institutional investors own about 5.6% of bioAffinity Technologies's shares, spread across 23 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.82% of BIAF.
The largest institutional holders are Sabby Management, LLC (4.06%), Blackrock Inc. (1.10%) and Vanguard Capital Management LLC (0.62%). Together, the top 10 institutions control 8.3% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their BIAF positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BIAF
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Sabby Management, LLC | 24.38K | 4.06% | +100.0% |
| Blackrock Inc. | 6.58K | 1.10% | +100.0% |
| Vanguard Capital Management LLC | 3.70K | 0.62% | 0.0% |
| Geode Capital Management, LLC | 3.40K | 0.57% | +5.5% |
| J. Safra Sarasin Holding AG | 2.84K | 0.47% | 0.0% |
| Vanguard Fiduciary Trust Co | 2.07K | 0.34% | 0.0% |
| Susquehanna International Group, LLP | 1.79K | 0.30% | +100.0% |
| Jane Street Group, LLC | 1.79K | 0.30% | +100.0% |
| State Street Corporation | 1.61K | 0.27% | +67.5% |
| HRT Financial LP | 1.39K | 0.23% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BIAF
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 3.70K | 0.62% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 1.66K | 0.28% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 509 | 0.08% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 434 | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 167 | 0.03% |
Frequently asked questions
Who is the largest shareholder of bioAffinity Technologies?
Sabby Management, LLC is the largest institutional shareholder of BIAF, owning 4.06% of shares outstanding (24.38K shares) as of its latest 13F filing.
What percentage of bioAffinity Technologies is owned by institutions?
Institutions own about 5.6% of BIAF shares and 5.6% of the public float.
How much of bioAffinity Technologies do insiders own?
Insiders, such as officers and directors, own about 0.82% of BIAF shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.